The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: a PET study of schizophrenic patients
Abstract
OBJECTIVE: Central D1, D2, and 5-HT2 receptor occupancy in schizophrenic patients treated with clozapine was determined and related to clozapine serum concentrations. METHOD: Seventeen patients treated with clozapine (125-600 mg/day) were examined with positron emission tomography (PET) and one to three of the following selective radioligands: [11C]SCH23390 (N = 11), [11C]raclopride (N = 16), and [11C]N-methylspiperone (N = 5). Clozapine concentration in serum was determined by gas chromatography/mass spectrometry. RESULTS: D2 receptor occupancy (20%-67%) was lower than that previously determined in patients treated with classical neuroleptics (70%-90%). D1 receptor occupancy (36%-59%) was higher than that induced by classical neuroleptics (0%-44%). 5-HT2 receptor occupancy was very high (84%-94%), even at low clozapine doses. Despite a 20-fold range in clozapine serum concentration (105-2121 ng/ml) at the time of PET examination, D2 receptor occupancy was low in all patients and was not described by the curvilinear relationship between serum drug concentration and receptor occupancy that has been demonstrated for classical antipsychotics. CONCLUSIONS: The results confirm in an extended series of patients that clozapine is atypical with regard to degree of D2 receptor occupancy, a finding that may explain the lack of extrapyramidal side effects. The combination of relatively high D1, low D2, and very high 5-HT2 receptor occupancy values is unique to clozapine. Clozapine serum concentrations have not been unequivocally shown to predict clinical effects. In this study, concentration did not predict degree of occupancy in brain. Thus, careful clinical titration cannot be replaced by monitoring of drug concentrations for optimization of clozapine treatment in individual patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clozapine for the Treatment-Resistant Schizophrenic: A Double-blind Comparison With Chlorpromazine
Kane, J. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800330013001 · Cited by 4,156
Farde, L. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820070032005 · Cited by 1,419
Meltzer, H. Y., Matsubara, S., & Lee, J. C. (1989) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20710-8 · Cited by 1,349
Quantitative Analysis of D2 Dopamine Receptor Binding in the Living Human Brain by PET
Farde, L., Hall, H., Ehrin, E., & Sedvall, G. (1986) · Science · doi:10.1126/science.2867601 · Cited by 831
Handbook of Experimental Pharmacology, vol 14.
Freedman, A. D. (1972) · Archives of Internal Medicine · doi:10.1001/archinte.1972.03650020118031 · Cited by 774
Central D2-Dopamine Receptor Occupancy in Schizophrenic Patients Treated With Antipsychotic Drugs
Farde, L. (1988) · Archives of General Psychiatry · doi:10.1001/archpsyc.1988.01800250087012 · Cited by 692
Nordström, A.-L., Farde, L., Wiesel, F.-A., Forslund, K., Pauli, S., Halldin, C., & Uppfeldt, G. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90288-o · Cited by 527
The significance of dopamine-receptor blockade for the mechanism of action of neuroleptic drugs.
van Rossum, J. M. (1966) · PubMed · Cited by 510
An overview of the mechanism of action of clozapine.
Meltzer, H. Y. (1994) · PubMed · Cited by 282
Mechanisms of action of atypical antipsychotic drugs
Deutch, A. Y., Moghaddam, B., Innis, R. B., Krystal, J. H., Aghajanian, G. K., Bunney, B. S., & Charney, D. S. (1991) · Schizophrenia Research · doi:10.1016/0920-9964(91)90030-u · Cited by 253
Clozapine: neuroleptic-induced EPS and tardive dyskinesia
Casey, D. E. (1989) · Psychopharmacology · doi:10.1007/bf00442559 · Cited by 251
5-HT2 and D2 dopamine receptor occupancy in the living human brain: A PET study with risperidone
Nyberg, S., Farde, L., Eriksson, L., Halldin, C., & Eriksson, B. (1993) · Psychopharmacology · doi:10.1007/bf02251280 · Cited by 227
Hasegawa, M., Gutierrez-Esteinou, R., Way, L. E., & Meltzer, H. Y. (1993) · PubMed · Cited by 189
Halldin, C., Stone-Elander, S., Farde, L., Ehrin, E., Fasth, K.-J., Långström, B., & Sedvall, G. (1986) · International Journal of Radiation Applications and Instrumentation. Part A. Applied Radiation and Isotopes · doi:10.1016/0883-2889(86)90044-4 · Cited by 174
Relationship Between Clinical Efficacy and Clozapine Concentrations in Plasma in Schizophrenia
Hasegawa, M., Gutierrez-Esteinou, R., Way, L. E., & Meltzer, H. Y. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199312000-00003 · Cited by 155
Nordström, A., Farde, L., Eriksson, L. I., & Halldin, C. (1995) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(95)02732-d · Cited by 149
Smith, M., Wolf, A. P., Brodie, J. D., Arnett, C. D., Barouche, F., Shiue, C., Fowler, J. S., Russell, J. A. G., MacGregor, R. R., Wolkin, A., et al. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90048-0 · Cited by 141
Baron, J., Martinot, J. L., Cambon, H., Boulenger, J.-P., Poirier, M. F., Caillard, V., Blin, J., Huret, J. D., Loc’h, C., & Maziere, B. (1989) · Psychopharmacology · doi:10.1007/bf00589893 · Cited by 127
Plasma clozapine concentrations as a predictor of clinical response: a follow-up study.
Miller, D. D., Fleming, F. J., Holman, T. L., & Perry, P. J. (1994) · PubMed · Cited by 115
Evaluation of the Karolinska new positron camera system; the Scanditronix PC2048-15B
Litton, J., Holte, S., & Eriksson, L. I. (1990) · IEEE Transactions on Nuclear Science · doi:10.1109/23.106708 · Cited by 103
High 5-HT2 receptor occupancy in clozapine treated patients demonstrated by PET
Nordström, A., Farde, L., & Halldin, C. (1993) · Psychopharmacology · doi:10.1007/bf02251294 · Cited by 102
Nyberg, S., Nakashima, Y., Nordström, A., Halldin, C., & Farde, L. (1996) · The British Journal of Psychiatry · doi:10.1192/s0007125000298309 · Cited by 77
Farde, L., & von Bahr, C. (1990) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1990.tb05292.x · Cited by 50
Clozapine and D1/D2Antagonism in Extrapyramidal Functions
Gerlach, J., & Hansen, L. H. (1992) · The British Journal of Psychiatry · doi:10.1192/s000712500029689x · Cited by 43
Hall, H. (1995) · European Neuropsychopharmacology · doi:10.1016/0924-977x(94)00127-w · Cited by 31
Cited by
Kapur, S., Zipursky, R., Jones, C., Remington, G., & Houle, S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.4.514 · Cited by 1,090
Miyamoto, S., Duncan, G. E., Marx, C. E., & Lieberman, J. A. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001556 · Cited by 988
Atypical antipsychotics: Mechanism of action
Seeman, P. (2002) · The Canadian Journal of Psychiatry · doi:10.1177/070674370204700106 · Cited by 899
Do Novel Antipsychotics Have Similar Pharmacological Characteristics? A Review of the Evidence
Arnt, J. (1998) · Neuropsychopharmacology · doi:10.1016/s0893-133x(97)00112-7 · Cited by 715
Kapur, S., Zipursky, R. B., & Remington, G. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.286 · Cited by 712
Metadata
- Venue
- American Journal of Psychiatry
- Published
- 1995-10-01
- Volume
- 152
- Issue
- 10
- Pages
- 1444-1449
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W162223338
- Cited by
- 339
- References
- 25
- FWCI
- 19.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.